Robotic Single Port Combined Umbilical and Inguinal Hernia Repair (CAPPUCCINOH)
Combined APProach of Umbilical ConComitant With Inguinal Hernia
Studie Overzicht
Toestand
Gedetailleerde beschrijving
The CAPPUCCINOH study (Combined APProach of Umbilical ConComitant with Inguinal Hernia Repair) is a prospective single-centre, single-arm cohort study conducted at AZ Maria Middelares, Ghent, Belgium. The study evaluates a novel surgical technique combining robotic-assisted inguinal hernia repair with concomitant umbilical hernia repair using the da Vinci Single Port (SP) system.
Building on the feasibility demonstrated in the ESPRITH study, the umbilical hernia defect is used as the single access site for the robotic procedure. Following inguinal hernia repair, the umbilical defect is repaired either by primary closure or with preperitoneal mesh reinforcement according to current guidelines and defect size.
The primary objective is to assess the safety and feasibility of this approach by evaluating operative time, technical errors, successful mesh placement, and perioperative complications. Secondary objectives include assessment of patient-reported outcomes, quality of life, body image, and hernia recurrence at one year postoperatively.
Patients will be followed for one year after surgery, with evaluations performed during hospitalization and at one month and one year postoperatively. The study aims to generate clinical evidence on the safety, effectiveness, and patient experience of robotic single-port repair for concomitant inguinal and umbilical hernias.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Filip Muysoms, MD, PhD
- Telefoonnummer: +32477325710
- E-mail: filip.muysoms@gmail.com
Studie Contact Back-up
- Naam: Jolien Lansens, Sc
- Telefoonnummer: +3292461854
- E-mail: Jolien.Lansens@mijnziekenhuis.be
Studie Locaties
-
-
East-Flanders
-
Ghent, East-Flanders, België, 9000
- Werving
- AZ Maria Middelares
-
Contact:
- Filip Muysoms, MD, PhD
- Telefoonnummer: +32477325710
- E-mail: filip.muysoms@gmail.com
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Adults with a primary inguinal hernia, either unilateral or bilateral, in association with a primary umbilical hernia of >1
Exclusion Criteria:
- recurrent inguinal hernia after preperitoneal repair
- irreducible scrotal hernia
- post-prostatectomy
- laparotomy in the lower abdomen
- pregnancy
- contra-indication for general anaesthesia
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Robotic Single-Port Inguinal and Concomitant Umbilical Hernia Repair
|
Robotic surgical platform used to perform single-port robotic inguinal hernia repair with concomitant umbilical hernia repair through a single umbilical access site.
Robotic single-port inguinal hernia repair with concomitant umbilical hernia repair through a single umbilical access site using the da Vinci SP system.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Technical errors with the robotic system
Tijdsspanne: During surgery
|
Number and type of technical errors or device-related issues encountered during the procedure.
|
During surgery
|
|
Operative time
Tijdsspanne: During surgery
|
Total operative time from skin incision to skin closure
|
During surgery
|
|
Complication Rate
Tijdsspanne: From surgery until 1 month postoperatively
|
Intraoperative, in-hospital and postoperative complications classified according to the Clavien-Dindo classification
|
From surgery until 1 month postoperatively
|
|
Success rate
Tijdsspanne: From surgery until planned follow-up 1 month potoperatively
|
success rate of preperitoneal mesh placement
|
From surgery until planned follow-up 1 month potoperatively
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Body Image Questionnaire Score
Tijdsspanne: Preoperatively, 1 month , and 1 year postoperatively
|
Patient-reported body image assessed using the Body Image Questionnaire.
The questionnaire evaluates patient satisfaction with physical appearance and cosmetic outcomes
|
Preoperatively, 1 month , and 1 year postoperatively
|
|
EuraHS Quality of Life score
Tijdsspanne: Preoperatively, 1 month and 1 year postoperatively
|
Patient-reported quality of life assessed using the European Registry for Abdominal Wall Hernias Quality of Life (EuraHS-QoL) Questionnaire, a validated instrument evaluating pain at the hernia site, restriction of activities, and cosmetic discomfort.
The total EuraHS-QoL score ranges from 0 to 90, with lower scores indicating better quality of life and less symptom burden, and higher scores indicating worse quality of life and greater symptom burden
|
Preoperatively, 1 month and 1 year postoperatively
|
|
Number of Participants With Hernia Recurrence
Tijdsspanne: 1 year postoperatively
|
Number of participants with a recurrent ventral hernia within 1 year after surgery.
Hernia recurrence will be assessed clinically and confirmed by ultrasound when clinically indicated.
|
1 year postoperatively
|
Medewerkers en onderzoekers
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- CAPPUCCINOH
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .